COVID-19 Research
As the novel coronavirus (COVID-19) continues to cause disruptions across the country, researchers at 91女神 are mobilizing to curb the pandemic and mitigate its effects.
More than 60 student and faculty researchers from 20 departments are studying this pandemic and its broader effects. Informed by our university鈥檚 Jesuit mission, these researchers are eager to serve those impacted by this pandemic, particularly those made most vulnerable during this difficult time.
The Race for a Vaccine
Hear three 91女神 researchers discuss how 91女神鈥檚 world-class vaccine research and development is fighting disease around the world with the help of our local St. Louis community.
With over 30 years of experience and more than 7,000 square feet of research and clinical spaces, the 91女神 Center for Vaccine Development (CVD) is home to the region鈥檚 leading experts in vaccine and treatment research. The CVD is also home to one of only 10 elite, NIH-funded in the country.
As a member of the , a newly organized network formed by the National Institute of Allergy and Infectious Diseases (NIAID) to develop and test vaccines and treatments in the fight against COVID-19, 91女神 is recruiting for large-scale vaccine trials that will enroll thousands of participants. The first of these trials began at 91女神 in August 2020 to test the effectiveness, safety and immune response generated by a vaccine co-developed by scientists at Moderna and the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center. The second of these trials was announced in December 2020; The 91女神 Center for Vaccine Development will be a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson鈥檚 Phase 3 clinical research study, ENSEMBLE trial, to evaluate the safety and efficacy of Janssen鈥檚 investigational COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S.
Researchers with the Center for Vaccine Development also conducted a study in March 2020 to test the safety and effectiveness of remdesivir in treating COVID-19.
Information on all of this research and more can be found at the link below.
COVID-19 Vaccine and Treatment Research at 91女神
Tracking COVID-19
Research to track the spread of COVID-19 and its broader effects is crucial in our response to the pandemic. Data gathered from this research can inform effective and equitable public health policy and highlight where best to focus resources.
91女神 researchers from a variety of fields are tracking the spread of COVID-19, as well as related factors such as citizens鈥� mobility following the implementation and the lifting of stay-at-home orders, the location of infection hot spots, and the effectiveness of regional mask mandates. is leading these efforts.
More information on this research, as well as other COVID-19 geospatial research, can be found on our dedicated Tracking COVID-19 page at the link below.
The Rapid Response COVID-19 Seed Fund
With generous support from Dr. Jeanne and Rex Sinquefield, The 91女神 Research Institute established a Rapid Response COVID-19 Seed Fund in Spring 2020 to support faculty-led pilot projects related to coronaviruses and mitigating the pandemic's broader effects.
The Seed Fund empowered 91女神 researchers from a broad range of disciplines, from communication to psychology to immunology and more, to act quickly in confronting this multifaceted crisis. The Research Institute awarded nearly $300,000 from the Seed Fund in two rounds in May 2020 and June 2020.
A complete list of funded projects can be found at the link below.
Rapid Response COVID-19 Seed Fund Projects
A Multidisciplinary Approach to the Pandemic
Researchers from across the University are engaged in research and scholarship to improve our understanding of this pandemic and develop solutions. Below is a sample of the University's multidisciplinary approach to this vital work.
- In February 2020, Steve Rigdon, Ph.D., professor of epidemiology and biostatistics, co-authored a new book entitled 鈥溾�� with Ron Fricker, a professor in the Department of Statistics at Virginia Tech. Using a variety of examples throughout history, the book details how statisticians identify and track outbreaks, giving insight into how biostatisticians and epidemiologists can help end the spread of COVID-19.
- Enbal Shacham, Ph.D., professor of public health, and Tim Wiemken, Ph.D., associate professor from 91女神COR, are examining the timing and relationship of increased negative flu tests and influenza type illness (ILI).
- Lauren Arnold, Ph.D., associate professor of epidemiology, has undertaken educational efforts in local schools and university-settings focused on facts and transmission risks. She is developing a survey to examine knowledge, attitudes, behaviors and fears about coronavirus among student populations.
- 91女神 researchers and instructors are consulting with school districts, health care systems, response personnel and federal agencies advising them on incident management and the coordination of hospitals and Emergency Operations Centers around the Midwest. They plan to develop response guidelines for infection preventionists and health care epidemiologists and to partner with the CDC on their recommendations related to hospitals and first responder infection prevention.
- 91女神 researchers and instructors are assisting local public health agencies in their response to this pandemic by assisting at emergency operations centers (EOC), helping with data analysis, developing health communication messages and answering questions from the general public.
- Terri Rebmann, Ph.D., professor of epidemiology and biostatistics, is serving on the Association for Professionals in Infection Control and Epidemiology (APIC) COVID-19 Task Force that was recently established. Rebmann, who is also the associate dean for academic and faculty affairs in the College for Public Health and Social Justice and the director of the Institute for Biosecurity, and the other task force members recently developed on the availability of Personal Protective Equipment (PPE) in US hospitals. The survey found that nearly half (48%) of U.S. health care facilities are already out of or almost out of N95 respirators that are vital in the care of patients with COVID-19. Many hospitals also reported a lack of hand sanitizer and cleaning supplies.
- Rebmann also presented an on-demand webinar from the American Nurses Association (ANA) that focused on the current PPE guidelines for supply optimization and how to maintain personnel safety. [https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=&eventid=2234864&sessionid=1&key=5E31A3A9FBDD1ADD2139EE46A9593DCE®Tag=&sourcepage=register] Register now and receive access to this online, on-demand webinar and view it anytime, anywhere.
- In February 2020, Wiemken and Ana Santos Rutschman, S.J.D., assistant professor in the Center for Health Law Studies, began the 鈥淚mmunization Science and Policy Partnership at 91女神.鈥� Funded through a Spark Microgrant from the 91女神 Research Institute, the partnership aims to bring together experts working on topics at the intersection of vaccine science and policy. This work complements 91女神鈥檚 internationally renowned vaccine development and clinical research. Though this project is still in its early stages, Rutschman and Wiemken are considering the COVID-19 pandemic as work on the project continues.
- Rob Gatter, J.D., professor in the Center for Health Law Studies, is serving on the St. Louis County Health Department COVID-19 Response Team. Gatter was named to the position by St. Louis County Executive Sam Page to assist the county health department with reviewing and drafting policies aimed at fighting the spread of COVID-19. Gatter is a nationally recognized expert in public health law and pandemic preparedness, including quarantine legality.
- On March 14, Gatter and Rutschman penned offering additional recommendations for formal quarantine orders during the coronavirus crisis.
- Cort W. Rudolph, Ph.D., associate professor of psychology, is studying the impact of the pandemic on the workforce. An expert in industrial and organizational psychology, Rudolph is examining how the pandemic is shaping work-related processes, practices, and policies, including those related to job stress, occupational health and wellbeing, job insecurity, and more. Rudolph is also studying what this crisis means for the aging workforce and how this crisis is being framed in terms of 鈥済enerations鈥� and 鈥済enerational differences.鈥� He recently co-authored .
- Clinical psychologists at 91女神 have created a new hotline for frontline health care workers at SSM Health hospitals. The hotline will allow those on the frontlines of the COVID-19 pandemic to care for their psychological and mental health during this time of pandemic. The hotline has been established by the Department of Psychiatry and Behavioral Neuroscience in 91女神鈥檚 School of Medicine and the Department of Psychology in the College of Arts and Sciences in partnership with Saint Louis Behavioral Medicine Institute (SLBMI).
- The COVID-19 pandemic has underscored and exacerbated a variety of existing issues
regarding inequity. Black Americans are dying at higher rates compared to others diagnosed
with COVID-19. The Institute for Healing Justice & Equity at 91女神 is bringing together researchers, scholars, activists, health care practitioners
and community leaders to examine this problem. The Institute has launched "The Color of COVID," a webinar series to discuss the growing crisis and its impact on black Americans.
- The first session, entitled "Stopping the Trend," was facilitated by Keon Gilbert, Dr.PH., associate professor of behavioral science and health education and a co-founder of the institute, and brought together experts from a variety of fields to discuss the existing inequalities contributing to long standing health inequities and their relationship to COVID-19 and outline solutions and action steps that can be taken to stop the trend. The session can be viewed in its entirety .
- The second session, entitled "Healing Justice Approaches to Self and Community Care," was facilitated by Kira Banks, Ph.D., associate professor of psychology and a co-founder of the institute, and highlighted practitioners who have taken innovative approaches to healing justice before and during the pandemic.
- Ruqaiijah Yearby, J.D., M.P.H., professor of Law and executive director of the Institute for Healing Justice and Equity, is examining how structural racism has caused racial and ethnic disparities in COVID-19 infection and death rates. Yearby recently co-authored an article on this with Seema Mohapatra, J.D., M.P.H., of Indiana University entitled which was published in the June 2020 edition of the Journal of Law and the Biosciences.
-
Yearby and Mohapatra also recently published that disproportionately affect women of color and low-wage workers, particularly within the home health care and meat-packing industries. Yearby and Mohapatra were then interviewed by Public Health Law Watch for their concerning vulnerable workers in the time of COVID.
In the News
In addition to their research, subject matter experts at 91女神 are sharing their expertise with the public.
06/16/21- Ana Santos Rutschman, J.D. (Law) was quoted in a Forbes article on the legality of businesses requiring their employees to get the COVID-19 vaccine.
06/11/21- 91女神's advisor to the President on COVID-19 will be honored June 28 by the Association for Professionals in Infection Control and Epidemiology (APIC). She was instrumental in helping lead the University's response to the pandemic, allowing 91女神 to stay open and hold mostly in person throughout the 2020-2021 academic year.
05/28/21- Timothy Wiemken, Ph.D. (Infectious Diseases) was quoted in a St. Louis Public Radio story about summer festivals and COVID protocols.
04/19/21- Terri Rebmann, Ph.D., RN, CIC, FAPIC, professor of epidemiology and biostatistics, director of the Institute for Biosecurity and special assistant to the president, was quoted by Healthday discussing vaccine hesitancy.
03/14/21- Chris Prener, Ph.D. (Sociology and Anthropology) was quoted in the St. Louis Post-Dispatch on the data around how the state of Missouri is shuffling vaccine doses.